These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33314118)

  • 1. Brivaracetam as add-on treatment in focal epilepsy: A real-world time-based analysis.
    Lattanzi S; De Maria G; Rosati E; Didato G; Chiesa V; Ranzato F; Canafoglia L; Cesnik E; Anzellotti F; Meletti S; Pauletto G; Nilo A; Bartolini E; Marino D; Tartara E; Luisi C; Bonanni P; Marrelli A; Stokelj D; Dainese F
    Epilepsia; 2021 Jan; 62(1):e1-e6. PubMed ID: 33314118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Fisco G; Gangitano M; Giallonardo AT; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation.
    Adewusi J; Burness C; Ellawela S; Emsley H; Hughes R; Lawthom C; Maguire M; McLean B; Mohanraj R; Oto M; Singhal S; Reuber M
    Epilepsy Behav; 2020 May; 106():106967. PubMed ID: 32179501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center.
    Green SF; Hare N; Kassam M; Rugg-Gunn F; Koepp MJ; Sander JW; Rajakulendran S
    Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.
    Steinig I; von Podewils F; Möddel G; Bauer S; Klein KM; Paule E; Reif PS; Willems LM; Zöllner JP; Kunz R; Runge U; Kurlemann G; Schubert-Bast S; Rosenow F; Strzelczyk A
    Epilepsia; 2017 Jul; 58(7):1208-1216. PubMed ID: 28480518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
    Foo EC; Geldard J; Peacey C; Wright E; Eltayeb K; Maguire M
    Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic.
    Stephen L; Brodie MJ
    Epilepsy Behav; 2021 Mar; 116():107746. PubMed ID: 33517200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
    Hirsch M; Hintz M; Specht A; Schulze-Bonhage A
    Seizure; 2018 Oct; 61():98-103. PubMed ID: 30118932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
    Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures.
    Lattanzi S; Ascoli M; Canafoglia L; Paola Canevini M; Casciato S; Cerulli Irelli E; Chiesa V; Dainese F; De Maria G; Didato G; Di Gennaro G; Falcicchio G; Fanella M; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    Epilepsia; 2022 May; 63(5):e42-e50. PubMed ID: 35278335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRIVEST: A 'real-world' observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam.
    Naddell S; Manuel M; Cavill R; White P; Sieradzan K
    Epilepsy Behav; 2023 Jan; 138():108985. PubMed ID: 36442261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST).
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Irelli EC; Chiesa V; Dainese F; De Maria G; Didato G; Gennaro GD; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    Seizure; 2022 Apr; 97():37-42. PubMed ID: 35320736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe.
    Steinhoff BJ; Christensen J; Doherty CP; Majoie M; De Backer M; Hellot S; Leunikava I; Leach JP
    Epilepsy Res; 2020 Sep; 165():106329. PubMed ID: 32623096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study.
    Menzler K; Mross PM; Rosenow F; Schubert-Bast S; Willems LM; Zahnert F; Immisch I; Fuest S; von Podewils F; Kunz R; Hirsch M; Mueller T; Marquetand J; Winter Y; Langenbruch L; Cicanic M; Beyenburg S; Strzelczyk A; Knake S
    BMJ Open; 2019 Nov; 9(11):e030746. PubMed ID: 31690606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brivaracetam for the treatment of refractory epilepsy in patients with prior exposure to levetiracetam: A retrospective outcome analysis.
    Snoeren A; Majoie MHJM; Fasen KCFM; Ijff DM
    Seizure; 2022 Mar; 96():102-107. PubMed ID: 35184005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents.
    Schubert-Bast S; Willems LM; Kurlemann G; Knake S; Müller-Schlüter K; Rosenow F; Strzelczyk A
    Epilepsy Behav; 2018 Dec; 89():89-93. PubMed ID: 30390435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
    Klein P; Schiemann J; Sperling MR; Whitesides J; Liang W; Stalvey T; Brandt C; Kwan P
    Epilepsia; 2015 Dec; 56(12):1890-8. PubMed ID: 26471380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brivaracetam efficacy and safety in focal epilepsy.
    Makke Y; Abou-Khalil B
    Expert Rev Neurother; 2019 Oct; 19(10):955-964. PubMed ID: 31195850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.